High-throughput techniques have uncovered hundreds and thousands of long non-coding RNAs (lncRNAs). Among them, only a small fraction has experimentally validated functions (EVlncRNAs) by low-throughput methods.
Introduction
Advances in high-throughput sequencing and microarray technologies showed that most of the human genome transcribe into RNAs despite they were not coded for proteins [1] [2] [3] . Among these non-coding RNAs (ncRNAs), long transcripts (>200 nucleotides) with unknown functions were found prevalent with low expression, highly tissue-specific, and lack of strong cross-species conservation [4] [5] [6] . Some long ncRNAs (lncRNAs) have been confirmed as functional and disease-relevant using traditional low throughput techniques such as qRT-PCR, knockdown, Western blot, Northern blot, and luciferase reporter assays [7] [8] [9] [10] [11] . So far, more than 1000 lncRNAs in >70 species were experimentally validated and collected in a number of databases (lncRNADisease, lncRInter, lncRNAdb, PLNlncRBase) [12] [13] [14] [15] . These databases were integrated into the comprehensive EVlncRNAs database [16] , which collected all known EVlncRNAs up to May, 2016 from 77 species.
The experimentally validated lncRNAs (EVlncRNAs), however, are only a tiny fraction of all transcribed ones. What percentage of transcribed lncRNAs is functional remains a subject of active debate [17] . It is known that some lncRNAs can be expressed due to lack of fidelity in transcription initiation by RNA polymerase II [18] .
Hon et al. [19] found that 69% of 27,919 FANTOM CAT lncRNAs overlap with traitassociated single nucleotide polymorphisms. However, the overlap could be due to their genomic positions, rather than intrinsic functions coded in sequences [20] . Nevertheless, 31% lncRNAs remain unaccounted for. Liu et al. [21] , on the other hand, found that only 3% (499/16, 401) lncRNA loci are essential for robust cell growth, based on a large-scale knockdown using a CRISPR interference technique. More importantly, analysis of mutational loads suggests that "the functional fraction within the human genome cannot exceed 25% and is probably considerably lower" [22] . Thus, a significant portion of transcribed lncRNAs is possibly non-functional.
Existence of non-functional but transcribed lncRNAs calls for computational methods to prioritize potentially functional lncRNAs prior to expensive and laborious experimental validations. Current computational tools on identification of lncRNAs have been focused on distinguishing expressed lncRNAs from coding RNAs [23] , a challenging problem as some lncRNAs were coded for short peptides while others such as H19, Xist, Mirg, and Gtl2 have predicted coding regions of longer than 100 amino acids [24, 25] . One approach for lncRNA identification is cross-species comparison.
Examples are CRITICA [26] , PhyloCSF [27] , CSTMiner [28] and RNAcode [29] .
Because the majority of lncRNAs are not conserved across different species, many methods estimated coding potentials of a sequence by using a wide variety of features and machine-learning techniques. Examples are CPAT by logistic regression model [30] , lncRNA-ID [31] , lncRNApred [32] , FEELnc [33] and COME [34] based on random forest and PORTRAIT [35] , CNCI [36] , CPC [37] , PLEK [38] and lncRScan-SVM [39] based on support vector machines. Using high-throughput experimental data have proven useful for further improving the accuracy of discrimination of lncRNAs from mRNAs [34, [40] [41] [42] .
In this study, we address the question whether or not lncRNAs experimentally validated (EVlncRNAs) by low throughput techniques are distinguishable from those lncRNAs obtained from high throughput experiments (HTlncRNAs). By using support vector machines and employing sequence-derived and HT experimental features in combination or separately, we showed that experimentally validated lncRNAs are identifiable from HTlncRNAs and mRNAs with reasonable accuracy. Moreover, a method trained and tested from human datasets is applicable to mouse RNAs with similar accuracy and to plant RNAs with somewhat lower accuracy. This indicates the robustness of the method developed for locating functional lncRNAs. The online server of EVlncRNA-pred is freely available at http://biophy.dzu.edu.cn/lncrnapred/index.html.
Results

Model performance for the full-feature model
Using positive samples collected in the EVlncRNAs dataset [16] and negative samples from lncRNAs and mRNAs from GENCODE [43] (see Methods), we built the training set from human RNAs and independent test sets from human, mouse and plant RNAs. Table 1 shows the results of the human 10-fold cross-validation and independent test by the support vector machines (SVM) model with 33 features (the full-feature model).
The corresponding ROC curves are shown in Figure 1 . The results indicate that the model performs better on the test set (MCC at 0.60 compared to 0.51, AUC at 0.88 compared to 0.84). This is likely due to a slightly larger training set (799 positive samples) than in the cross validation (719 positive samples). When the model is further applied to mouse RNAs, there is a performance drop to the performance level similar to ten-fold cross validation. It should be noted that the lower precision for the mouse test set is due to higher sensitivity as the threshold was set by the 10-fold cross validation. If one adjusts the threshold to sensitivity of 0.64, one would obtain a precision of 0.74. Nevertheless, the low standard deviation in ten-fold cross-validation performance over 100 randomly selected ten folds and the consistently high, cross-species performance (AUC>0.84) in independent tests confirm the overall quality and robustness of the model developed.
Model performance for the sequence-only model
The above model employed some high-throughput experimental results including expression abundance and histone modification. However, these experimental data are not always available. Thus, we also built a model that requires the input of a sequence only. Table 1 and Figure 1 also present the results from the sequence-only model. The model performance is much more similar among the ten-fold cross validation and two independent tests (human and mouse test sets) with MCC=0.47, 0.51, 0.48 and AUC=0.84, 0.85, and 0.85, respectively. This overall performance is slightly worse than the case when experimental data were employed, confirming the usefulness of expression abundance and histone modification in EVlncRNA discrimination. On the other hand, if these experimental results are not available, the sequence-only model yields adequate accuracy in separating EVlncRNAs from HTlncRNAs and mRNAs as shown in Figure 1 and Table 1 .
Model performance for the plant test set
The ability of human-RNA trained model to predict mouse lncRNA indicates inherently similar characteristics of functional lncRNAs in human and mouse. It is of interest to know if plant EVlncRNAs can also be detected in a similar accuracy. In human and mouse, we used phastCons [44] scores provided by the UCSC [45] to represent the DNA sequence conservation. However, UCSC do not have phastCons scores of Arabidopsis thaliana. Thus, we re-trained all models without using DNA conservation scores. EVlncRNAs from plant to human. This also suggests that plant-specific training when sufficient data is available may be necessary to maximize the discrimination capability.
The importance of individual features
To examine the discrimination power of each feature group for separating EVlncRNAs from HTlncRNAs and mRNAs, we obtained the best performing single feature in each feature group according to 10-fold cross-validation and compare them in Figure 3 . For single-feature performance, the performance is measured by the difference between the AUC (DAUC) by the single feature group and 0.5 by random prediction or between the AUC by the full feature model and by the model after removing the single feature group. Figure 3 shows that according to feature removal, protein conservation has the highest DAUC value from the full feature mode at 0.031, followed by RNA conservation (DAUC = 0.020). The best experimental feature is the H3K4me3 modification group with the DAUC value at 0.008. These changes in DAUC are small.
We can also measure the changes in precision at a fixed value of sensitivity. The same trend is observed with two highest reductions of 10.3% and 8% in precision for removing protein and RNA conservation, respectively, and the largest reduction of 
Discrimination against mRNAs
Our method was designed to discriminate EVlncRNAs against both HTlncRNAs and mRNAs as all of our negative sets in training and test sets contain 1:1 ratio of mRNA :
HTlncRNAs. To further examine the capability of discrimination against mRNAs, we built an additional test set by using the EVlncRNAs in our test set as the positive set, and newly randomly selected mRNAs as an additional negative set. EVlncRNA-pred achieves a high AUC of 0.959, a precision of 0.987, a specificity of 0.991, and the MCC value of 0.675. This higher performance in mRNA discrimination is consistent with our intuition that separating EVlncRNAs from mRNAs is easier than separating them from HTlncRNAs.
Comparison with other methods
To the best of our knowledge, the method reported here is the first technique for discriminating EVlncRNAs from HTlncRNAs and mRNAs. Existing techniques for lncRNA prediction are dedicated to separate HTlncRNAs from mRNAs. We do not expect that they could be useful for identifying EVlncRNAs from HTlncRNAs and mRNAs. To confirm this, Figure 4 reported the applications of the logistic regression model CPAT [30] , the random forest model COME [34] , and support vector machines models CNCI [36] and PLEK [38] to the human test set. Indeed, CNCI, CPAT, and PLEK methods are close to random predictions at low false positive rates whereas COME is unable to make any positive prediction until false positive rates are greater than 0.2. Overall prediction of COME, CNCI, CPAT, and PLEK is better than random with AUCs ranging from 0.567, 0.672, 0.699, and 0.569, respectively. This is because mRNA belongs to the negative set whereas EVlncRNAs belongs to the positive set in training COME, CNCI, CPAT and PLEK. We would like to emphasize that the comparison made in Figure 4 is not to illustrate the improvement of our method over previous techniques but to highlight the difference in the prediction goals.
Case Studies
Tumour specific EVlncRNAs. Tumour-specific EVlncRNAs is a large group in all known EVlncRNAs. In the EVlncRNA database, there were 446 and 72 tumour-specific lncRNAs in our training and test sets, respectively. The sensitivity of EVlncRNA-pred (the fraction of predicted EVlncRNAs in known EVlncRNAs) is 54% for these tumourspecific lncRNAs in the training set and 57% in the test set, which are close to a sensitivity of 60% in ten-fold cross validation (Table 1) , suggesting overall consistency of the method performance for specific types of EVlncRNAs.
CRISPRi-identified functional lncRNAs. Recently Liu et al. (2017) developed a CRISPR
interference technique for a large-scale screening of lncRNA loci required for robust cell growth. Strictly speaking, the resulting 499 lncRNA loci discovered would require further validation by low-throughput experiments. However, it is of interest to examine the performance of EVlncRNA-pred for these newly discovered putatively functional lncRNAs. Among these 499 lncRNA loci, we located 194 lncRNAs with the gene structure information in the general transfer format, 59 lncRNAs of which are in the positive training set (known EVlncRNAs). Applying EVlncRNA-pred to the remaining 135 lncRNAs yields a sensitivity of 42%. It should be noted that the above putatively functional lncRNA loci were filtered with an experimental confidence score (called "screen score") >7. If we increase this threshold from 7, 15 to 25, the sensitivity of our method will improve from 42%, 49%, to 67%. Concurrent increase of our method sensitivity and the experimental confidence score confirms the ability of EVlncRNAs to locate truly functional lncRNAs.
Newly discovered EVlncRNAs. We conducted a literature search for newly discovered [46] found that a lncRNA, SNHG20, has a significantly higher expression in Colorectal Cancer (CRC) tissues than in corresponding normal tissues from 107 CRC patients. SNHG20 regulated cell growth through modulation of a series of cell cycle-associated genes. Similarly, Lu et al. [47] found that a higher expression level of a lncRNA, SOX21-AS1, positively correlated with the tumour size and the advanced stage of tumor-node-metastasis (TNM), and the inhibition of SOX21-AS1 induced p57 expression. SNHG20 and SOX21-AS1 are classified as EVlncRNAs by EVlncRNA-pred.
Discussion
We have developed a method termed EVlncRNA-pred for selecting potentially functional lncRNAs from expressing lncRNAs found in high-throughput sequencing. One revealing fact is that the most discriminating features are related to conservations at protein levels followed by RNA levels. It turns out that protein conservation is the most important for separating from mRNAs whereas RNA conservation is the most important for separating from HTlncRNAs. This result provides the additional confidence for the method developed. Although sequence conservation signal for lncRNA is in general weak [49] , it remains one essential feature for functional lncRNAs [50] [51] [52] [53] . The result reported here indicates that the conservation signal can be picked up by a machine learning technique to highlight the intrinsic difference between those experimentally validated lncRNAs and those somehow expressed in high-throughput sequencing.
Here, we assumed from the outset that all lncRNAs reported in GENCODE are negative samples after excluding experimentally validated ones. This assumption was made despite the training set may contain a significant number of false negatives, which are true functional lncRNAs yet to be validated by low throughput experiments. If the majority of the presumed negatives were false negatives, one would not be able to develop a method to separate positive from negatives during training. The fact that a highly robust method can be made indicates that false negatives are not dominant and there is a population in HTlncRNAs separable from known EVlncRNAs. The existence of such a population in HTlncRNAs distinct from known EVlncRNAs itself is interesting, as transcriptional noise could be a source for some of the lncRNAs found by high-throughput experiments [18] .
Using a negative set containing some false negatives is a common practice in machine learning because negatives are always more difficult to prove. For example, in studying pathogenic genetic variations, genetic variants found in 1000 genome projects on healthy individuals [54] are considered as neutral (non-disease causing) [55] .
However, this assumption may not be correct for some late-onset disorders, in particular. It was shown that removing potential false negatives (the genetic variants with low minor allele frequency and potentially pathogenetic [56] ) reduces the performance of the method trained. This suggests that having more data is more important than reducing potential false negatives in the training set [55] .
To further examine the effect of potential errors in negatives, we randomly added 5% or 10% errors to nine-folds in the training set by assigning HTlncRNAs to EVlncRNAs and EVlncRNAs to HTlncRNAs and testing the method for the remaining fold. This was repeated 10 times (ten-fold cross validation). We also randomly selected 5% or 10% errors 10 separate times to obtain an average effect. Introducing 5% and 10% errors leads to the average MCC values changed only slightly from 0.513 to 0.496 and 0.480, respectively. The small changes due to assignment errors indicate that our method is robust against potential assignment errors in the training set. However, one has to be cautious that not all positive predictions are functional lncRNAs as the fraction of correct predictions in positive predictions is at 81% for the human test set (i.e. 19% are incorrect). Moreover, the coverage of functional lncRNAs (sensitivity) is at 64% due to the small training set. That is, predictions may miss many functional RNAs, tissue-specific lncRNAs, in particular. Nevertheless, the method should be already useful for prioritizing potentially functional lncRNAs for further experimental validation. At the meantime, we hope to further improve sensitivity and precision in near future when a much larger dataset is available for deep learning.
To estimate the fraction of potentially functional EVlncRNAs in HTlncRNAs, we randomly selected 2000 human lncRNAs in NONCODE database [57] 
Materials and methods
Training and test datasets for human lncRNAs
Most previous methods for discriminating lncRNAs from mRNAs were trained by using lncRNAs from GENCODE [43] as the positive dataset. These lncRNAs were obtained from the ENCODE project [58] by using a variety of high-throughput techniques and annotated by a combination of computational analysis, sequence comparison and manual annotation. Here we treated them as the negative dataset after excluding all known experimentally validated, functional lncRNAs from a recently curated database EVlncRNAs [16] (the positive dataset). Because EVlncRNAs is far from a complete dataset for functional lncRNAs, our negative dataset likely contains some false negatives. As we discussed in the discussion section, this should not prevent us addressing the question if current experimentally validated lncRNAs (denoted as EVlncRNAs for convenience) are separable from lncRNAs from high-throughput (HT) experiments (denoted as HTlncRNAs for convenience).
We first created a positive human test set from EVlncRNAs that were not contained in GENCODE V19 so that we can create a set of newly discovered, experimentally validated lncRNAs. This test set was obtained by using CD-HIT [59] to remove redundant sequences with more than 80% sequence similarity with HTlncRNAs in GENCODE V19 and among themselves. We have chosen 80% sequence identity cutoff because statistics suggests a significant reduction in secondary structure similarity for RNA sequences with <80% sequence identity [60] . Moreover, it is the lowest sequence identity cutoff allowed by the program CD-HIT [59] . This cutoff was also employed previously for establishing non-redundant RNA sequences [61, 62] . A total of 117 human EVlncRNAs were obtained as an independent positive test set. The remaining human lncRNAs from EVlncRNAs were used to generate the positive training set after removing redundant sequences by CD-HIT from the independent test set and among themselves. This leads to a training set of 799 human EVlncRNAs. The negative sets for HTlncRNAs (799 training and 117 independent test HTlncRNAs) were randomly selected from GENCODE V19 while ensuring <80% sequence identity among themselves and from the positive sets.
In addition to the HTlncRNA set as the negative set, we also included mRNAs from GENCODE V19 as the negative set. These mRNAs were randomly selected with <80% sequence similarity between each other and from selected HTlncRNAs and EVlncRNAs. The number of mRNAs is set to the same as the size of the two positive sets. Thus, the final human training dataset contains 799 EVlncRNAs (positive), 799
HTlncRNAs (negative) and 799 mRNAs (negative). The final human independent test set contains 177 EVlncRNAs (positives), 177 HTlncRNAs (negatives) and 177 mRNAs (negatives). Using both HTlncRNAs and mRNAs in the negative sets is to ensure that our method can discriminate EVlncRNAs from either HTlncRNAs or mRNAs.
Here, we have set the ratio of EVlncRNA:HTlncRNA:mRNA to 1:1:1 in training and test sets. The purpose is to maximize the learning by undersampling the negative samples [48] . To examine the effect of the ratio, we also built the training set 
Independent test sets from mouse and plant lncRNAs
To further test the robustness of the methods developed, we established independent test sets by using mouse and plant lncRNAs. Similar to human datasets, the positive sets for plant and mouse were obtained from the EVLncRNAs database [16] . There were 166 mouse EVlncRNAs after removing redundant sequences with more than 80% sequence similarity to the human set (both positive and negative sets) and among themselves. We randomly selected 166 mouse HTlncRNAs from GENCODE V19 as the negative set after removing the redundant sequences from the mouse positive set, the human set and among themselves. In addition, we have randomly selected 166 mouse mRNA set from GENCODE V19 with the same sequence similarity cutoff to remove redundancy. The final mouse test set contains 166 EVlncRNAs (positives), 166 HTlncRNAs (negatives) and 166 mRNAs (negatives).
We used the EVlncRNAs of Arabidopsis thaliana in the EVLncRNAs database [16] to construct the positive set for plant. After removing redundant sequences with more than 80% sequence similarity with the human set and among themselves, 120
Arabidopsis thaliana EVlncRNAs were obtained as the plant positive set. The HTlncRNAs and mRNAs of Arabidopsis thaliana were from the Ensembl Plants database [63] . Similar to the mouse negative set, equal number of HTlncRNAs and mRNAs of Arabidopsis thaliana were randomly selected after removing the redundant sequences from the plant positive set, the human set, and among themselves. The final plant test set contains 120 EVlncRNAs (positives), 120 HTlncRNAs (negatives) and 120 mRNAs (negatives).
Input features
All features were block-averaged similar to previous studies [34, 36, 38, 64] . Each block has 100 nucleotides, centered at 50, 100, 150, and etc. until the entire sequence is covered by blocks. For a given feature, the value or averaged value of each block was DNA conservation score. The phastCons [44] scores provided by the UCSC [45] represented the DNA sequence conservation of human and mouse. The phastCons scores for human are from phastCons100way, and the scores for mouse are from phastCons60way. However, no similar scores are available for plant. We have simply set these values to zero when applying to the plant set (also see below).
Protein conservation score. The protein conservation score was calculated by BLASTx that searches a given nucleotide sequence against the protein sequence in the UniProt database [65] .
RNA conservation score. Infernal ("INFERence of RNA Alignment") [66] was employed for searching Rfam databases [67] for RNA structure and sequence similarities. It is an implementation of a special case of profile stochastic context-free grammars called covariance models (CMs). A CM is like a sequence profile, but it scores a combination of sequence conservation and RNA secondary-structure conservation.
Predicted solvent accessible surface area (ASA) of RNA. RNA ASA values were predicted by RNAsnap [61] .
Features based on high-throughput experimental results
The above sequence-based features together with the features based on high-throughput experimental results (see below) are utilised to develop the full-feature model.
Expression abundance. The reads per kilobase per million (RPKM) for each sequence were calculated from polyA+, polyA-and small RNA-seq data. The maximum scores for five cell lines (GM12878, K562, H1-hESC, HeLa-S3, and HepG2) were assigned to human sequence. For the mouse and Arabidopsis thaliana, the RNA-seq data of various tissues were used. These feature values were obtained from COME [34] .
Histone modification. The ChIP-seq data from H3K36me3 and H3K4me3 modification were used to calculate the signal over a sequence. The averaged input-normalized signals of five cell lines (GM12878, K562, H1-hESC, HeLa-S3, and HepG2) were used for human sequences. The ChIP-seq data of various tissues were used for sequences of mouse and Arabidopsis thaliana. These values were obtained from COME [34] .
Ribosome profiling is another possible experimental feature. However, a previous study suggested its minor contribution to discrimination of HTlncRNA from mRNA [34] . We expect that it is less useful for separating EVlncRNA from HTlncRNA as both are not translated into peptides or proteins. As a result, this feature was not employed in this study.
Support vector machines
We used SVM with the RBF kernel implemented in LIBSVM version 3.22 [68] to build our model. We optimized the parameters C and gamma using the grid search algorithm implemented in LIBSVM.
Cross validation and independent test
We performed 10-fold cross validation on the training set. In this cross validation, the training set was randomly divided into ten folds, and each fold was tested in turn by using the remaining nine folds for training. To examine whether the results are consistent for different divisions of the dataset, we conducted 10-fold cross validations 100 times by randomly dividing the training set 100 times. We also used the whole training set to train the model and tested the model on independent test sets.
Performance evaluation criteria
The performance of our method was evaluated by Matthews correlation coefficient (MCC), receiver operating characteristic (ROC) curve, area under the ROC curve (AUC), accuracy, sensitivity, specificity, and precision. The equations are as below. Precision is the fraction of true EVlncRNAs in all predicted EVlncRNAs.
Data and software availability
EVlncRNA-pred is available as a web server at http://biophy.dzu.edu.cn/lncrnapred/index.html. All datasets used in this study can be obtained from the same website. EVlncRNA-pred CPAT CNCI PLEK COME Random
